Hermouet, S., & Vilaine, M. (2011). The JAK2 46/1 haplotype: A marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection? Ferrata Storti Foundation.
Chicago ZitierstilHermouet, Sylvie, und Mathias Vilaine. The JAK2 46/1 Haplotype: A Marker of Inappropriate Myelomonocytic Response to Cytokine Stimulation, Leading to Increased Risk of Inflammation, Myeloid Neoplasm, and Impaired Defense against Infection? Ferrata Storti Foundation, 2011.
MLA ZitierstilHermouet, Sylvie, und Mathias Vilaine. The JAK2 46/1 Haplotype: A Marker of Inappropriate Myelomonocytic Response to Cytokine Stimulation, Leading to Increased Risk of Inflammation, Myeloid Neoplasm, and Impaired Defense against Infection? Ferrata Storti Foundation, 2011.